CoChat

Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism

Scahill, Larry, McCracken, James, McDougle, Christopher J., Aman, Michael, Arnold, L. Eugene, Tierney, Elaine, Cronin, Pegeen, Davies, Mark, Ghuman, Jaswinder, Gonzalez, Nilda, Koenig, Kathleen, Lindsay, Ronald, Martin, Andres, McGough, James, Posey, David J., Swiezy, Naomi, Volkmar, Fred, Ritz, Louise, Vitiello, Benedetto · 2001 · Journal of Child and Adolescent Psychopharmacology
Cited by 42

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To describe the methodological challenges and decisions made in developing a multisite, controlled study of risperidone in children and adolescents with autism. METHODS: Review the design considerations for clinical trials in children with autistic disorder accompanied by severe tantrums, aggressive and/or self-injurious behaviors. These design considerations include the definition of inclusion criteria that are relevant to clinical practice and matching study design to the goal of evaluating short- and long-term effects. Additional ethical and scientific issues concern the length of trial and sample size. RESULTS: We undertook a short-term, placebo-controlled study to evaluate the efficacy and safety of risperidone in children and adolescents with autistic disorder. This trial design was followed by an extended open-label maintenance on risperidone to confirm durability of treatment effects and to monitor safety. Finally, a placebo-controlled discontinuation study tested the need for continuous treatment. CONCLUSIONS: In the absence of standard pharmacological treatment for children with autistic disorder, a placebo-controlled study remains the most appropriate method of testing efficacy and safety. The clinical relevance of this study is enhanced by the addition of an extended maintenance phase followed by a placebo discontinuation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/104454601317261555

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 42

Metadata

Authors
Scahill, L., McCracken, J., McDougle, C. J., Aman, M., Arnold, L. E., Tierney, E., Cronin, P., Davies, M., Ghuman, J., Gonzalez, N., Koenig, K., Lindsay, R., Martin, A., McGough, J., Posey, D. J., Swiezy, N., Volkmar, F., Ritz, L., & Vitiello, B.
Venue
Journal of Child and Adolescent Psychopharmacology
Published
2001-12
Volume
11
Issue
4
Pages
377-388
ISSN
  • 1044-5463 (ISSN-L)
  • 1557-8992
OpenAlex
W2150753044
Cited by
42
References
3
FWCI
1.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism. https://app.cochat.ai/papers/10.1089/104454601317261555
The paper
Scahill, L., McCracken, J., McDougle, C. J., Aman, M., Arnold, L. E., Tierney, E., Cronin, P., Davies, M., Ghuman, J., Gonzalez, N., Koenig, K., Lindsay, R., Martin, A., McGough, J., Posey, D. J., Swiezy, N., Volkmar, F., Ritz, L., & Vitiello, B. (2001). Methodological Issues in Designing a Multisite Trial of Risperidone in Children and Adolescents with Autism. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/104454601317261555

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.